News from medac pharma, inc

May 14, 2014, 10:17 ET

Medac Pharma, Inc. Announces Successful FDA Inspection Of Its Exclusive Methotrexate Manufacturer

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing...

Apr 15, 2014, 10:17 ET

Medac Pharma, Inc. Secures FDA Approval of Trade Name Rasuvo™ for Lead Methotrexate Subcutaneous Injectable Product

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing...

Mar 11, 2014, 10:17 ET

Medac Pharma, Inc. Announces the Issuance of U.S. Patent for Treating Autoimmune Diseases with Concentrated Methotrexate Solutions of More Than 30 mg/ml

CHICAGO, March 11, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new...

Jan 27, 2014, 10:17 ET

Medac Pharma, Inc. Secures FDA Acceptance of a New Drug Application (NDA) for Methotrexate-Containing Autopen

 Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of...

Oct 21, 2013, 10:17 ET

Medac Pharma, Inc. Announces Multiple Poster Presentations During the 2013 ACR/ARHP Annual Meeting

 Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of...

Oct 16, 2013, 10:17 ET

Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO

 Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer